NO980058L - Opthalmiske preparater - Google Patents

Opthalmiske preparater

Info

Publication number
NO980058L
NO980058L NO980058A NO980058A NO980058L NO 980058 L NO980058 L NO 980058L NO 980058 A NO980058 A NO 980058A NO 980058 A NO980058 A NO 980058A NO 980058 L NO980058 L NO 980058L
Authority
NO
Norway
Prior art keywords
ophthalmic preparations
ophthalmic
prostaglandin
phenylene
inter
Prior art date
Application number
NO980058A
Other languages
English (en)
Norwegian (no)
Other versions
NO980058D0 (no
Inventor
Takashi Ikari
Yuzuru Matsumura
Tsutomu Nakamura
Motoyuki Yajima
Hajimu Kurumatani
Ayako Kawashima
Musafumi Isogaya
Hisanori Wakita
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO980058D0 publication Critical patent/NO980058D0/no
Publication of NO980058L publication Critical patent/NO980058L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO980058A 1996-05-07 1998-01-06 Opthalmiske preparater NO980058L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13769796 1996-05-07
PCT/JP1997/001504 WO1997041864A1 (fr) 1996-05-07 1997-05-01 Preparations ophtalmiques

Publications (2)

Publication Number Publication Date
NO980058D0 NO980058D0 (no) 1998-01-06
NO980058L true NO980058L (no) 1998-03-06

Family

ID=15204703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980058A NO980058L (no) 1996-05-07 1998-01-06 Opthalmiske preparater

Country Status (9)

Country Link
US (1) US6232343B1 (fr)
EP (1) EP0842663A4 (fr)
KR (1) KR19990028646A (fr)
CN (1) CN1126545C (fr)
AU (1) AU734650B2 (fr)
CA (1) CA2226348A1 (fr)
NO (1) NO980058L (fr)
TW (1) TW487573B (fr)
WO (1) WO1997041864A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717104B2 (en) * 1995-11-14 2000-03-16 Toray Industries, Inc. Ocular depressor
US6919372B1 (en) 1997-12-26 2005-07-19 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical compositions
US6804136B2 (en) 2002-06-21 2004-10-12 Micron Technology, Inc. Write once read only memory employing charge trapping in insulators
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070149480A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US20100227905A1 (en) * 2009-03-03 2010-09-09 Alcon Research, Ltd. Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
AU2010221438C1 (en) * 2009-03-03 2015-01-29 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
CN102319213B (zh) * 2011-09-08 2013-05-08 北京泰德制药股份有限公司 一种贝前列素酸纳米脂微球制剂
US9744192B2 (en) * 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8200407U1 (de) * 1982-01-11 1982-07-01 Fr. Poggenpohl KG, Möbelwerke, 4900 Herford Anbau-kuechenschrank
JPS58124778A (ja) 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPH0348655A (ja) * 1989-07-14 1991-03-01 Shionogi & Co Ltd プロスタグランジンｄ↓２類の安定化
TW205508B (fr) 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
JP3573480B2 (ja) * 1994-02-21 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
AU717104B2 (en) * 1995-11-14 2000-03-16 Toray Industries, Inc. Ocular depressor

Also Published As

Publication number Publication date
AU2650697A (en) 1997-11-26
CA2226348A1 (fr) 1997-11-13
NO980058D0 (no) 1998-01-06
CN1126545C (zh) 2003-11-05
CN1196681A (zh) 1998-10-21
TW487573B (en) 2002-05-21
EP0842663A1 (fr) 1998-05-20
KR19990028646A (ko) 1999-04-15
EP0842663A4 (fr) 2003-06-18
AU734650B2 (en) 2001-06-21
WO1997041864A1 (fr) 1997-11-13
US6232343B1 (en) 2001-05-15

Similar Documents

Publication Publication Date Title
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SE9504661D0 (sv) New compounds
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
CA2183972A1 (fr) Derives de l'oxazolidinone et compositions pharmaceutiques contenant ces derniers
MXPA03011510A (es) Derivados de5-halo-triptamina usados como ligandos de receptores de serotonina 5-ht-6 y/o 5-ht-7.
NO971625L (no) Nye peptider med immunomodulatoriske effekter
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
NO980058L (no) Opthalmiske preparater
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
DE60128100D1 (de) Analgetisches arzneimittel
DE69819539D1 (de) Antithrombotische mittel
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
SE9504662D0 (sv) New compounds
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
AU7470098A (en) Antithrombotic agents
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
RU95106652A (ru) Оптически активные производные карбоксамида, аналгезирующее средство
AU4944899A (en) New pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application